Tolvaptan, a selective oral vasopressin V2 receptor antagonist, ameliorates podocyte injury in puromycin aminonucleoside nephrotic rats

✍ Scribed by Tadashi Okada; Toshifumi Sakaguchi; Ikuji Hatamura; Fumie Saji; Shigeo Negi; Haruhisa Otani; Yasuteru Muragaki; Hiroshi Kawachi; Takashi Shigematsu

• Book ID: 106288385
• Publisher: Springer
• Year: 2009
• Tongue: English
• Weight: 695 KB
• Volume: 13
• Category: Article
• ISSN: 1342-1751
• DOI: 10.1007/s10157-009-0196-0